Stress Tests Equipment Market, By Product Type (Treadmill Stress Test, Ergometry, Cardiopulmonary Exercise Testing (CPET), Exercise ECG Systems, Echocardiogram), End-use (Hospitals & Clinics, Diagnostic Centers, ASCs) – Global Forecast (2024-2032)

Stress Tests Equipment Market, By Product Type (Treadmill Stress Test, Ergometry, Cardiopulmonary Exercise Testing (CPET), Exercise ECG Systems, Echocardiogram), End-use (Hospitals & Clinics, Diagnostic Centers, ASCs) – Global Forecast (2024-2032)

Stress Tests Equipment Market Size

Stress Tests Equipment Market was valued at USD 2.6 billion in 2023 and is anticipated to grow at a CAGR of around 6.5% between 2024 and 2032. Stress tests equipment refers to medical devices or systems designed for the purpose of conducting stress tests, which are diagnostic procedures to assess the performance and capacity of certain physiological functions under controlled or induced stress conditions. The increasing prevalence of cardiovascular diseases (CVDs) is a significant driver for the stress test equipment market. As the cardiovascular diseases represent a major global health concern and contribute to a high morbidity and mortality rate worldwide.
 

For instance, according to the American College of Cardiology, in 2023, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022. Thus, stress tests play a crucial role in the early detection of cardiovascular diseases, allowing healthcare professionals to identify potential issues before symptoms manifest.
 

Governments often launch public health campaigns to raise awareness about cardiovascular diseases and the importance of early detection. These campaigns include information about stress tests as essential diagnostic tools, contributing to increased public awareness and utilization. Further, government offer incentives or subsidies to healthcare providers to invest in advanced medical equipment, including stress test equipment. Financial support encourages healthcare facilities to upgrade their diagnostic capabilities, thereby driving market growth.

COVID-19 Impact

During the initial phase of the pandemic, healthcare resources were redirected towards COVID-19 care, leading to the postponement of non-urgent cardiac testing and elective procedures. This temporarily affected the demand for cardiac stress testing. Moreover, COVID-19 posed cardiovascular complications, including myocardial injury which elevated the need for cardiac testing in patients with COVID-19 to assess cardiac health and monitor potential damage. Hence, the stress testing equipment market experienced a period of decline during pandemic but later regained its momentum in the subsequent years.
 

Stress Tests Equipment Market Trends

Elderly and obese groups are more prone to cardiovascular diseases and related conditions, necessitating the use of stress tests for early detection, assessment, and management. As individuals age, the risk of developing conditions such as coronary artery disease and heart failure increases, the stress tests play a key role in the early detection of potential issues.
 

• Furthermore, obesity is closely linked to various cardiovascular risk factors, including hypertension, diabetes, and dyslipidemia, and it is among the leading causes of rising CVD mortality and morbidity. For instance, according to the Journal of the American Heart Association, obesity-related cardiovascular disease deaths tripled between 1999 and 2020 in the U.S.
   
• Thus, as the demographic landscape shifts towards an older and more obese population, the demand for stress test equipment is expected to grow, highlighting the critical role these diagnostic tools play in addressing cardiovascular health challenges in these patient groups.
   
• Moreover, the surging awareness of preventive healthcare is marking a paradigm shift in healthcare towards proactive health management. Preventive healthcare emphasizes early detection and intervention, aligning with stress tests' crucial role in assessing disease and identifying potential risks before symptoms manifest.
   

Stress Tests Equipment Market Analysis

The stress tests equipment market by product type is categorized into treadmill stress test systems, ergometry equipment, cardiopulmonary exercise testing (CPET) equipment, exercise ECG systems, echocardiogram, and supplies & accessories. The treadmill stress test systems segment held a substantial revenue share in the stress tests equipment market, accounting for 18.8% in 2023.
 

• The high growth rate of the segment is driven by its versatility as it is widely used for assessing cardiovascular health. The familiarity of walking or running on a treadmill makes it a preferred method for inducing physical stress during a stress test.
   
• Moreover, treadmills allow for dynamic and controlled exercise, facilitating a gradual increase in speed and incline to elevate the heart rate and induce stress, thus, contributing to the segment's expansion.

Based on end-use, the stress tests equipment market unfolds into distinctive domains such as hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end-users. The hospitals and clinics segment dominated the market with a 50.7% revenue share in 2023 and is projected to expand at a 6.9% CAGR from 2024 to 2032.
 

• This high segmental growth is attributed to their role as the primary healthcare facilities that provide comprehensive patient care for stress tests.
   
• They offer a wide range of diagnostic services through different types of products including treadmills, ECG stress test which is estimated to reach USD 5.2 billion by 2032, ergometry equipment, echocardiogram, among others, to address diverse patient needs.
   
• Additionally, stress tests are often part of cardiology departments' services, and hospitals and clinics seamlessly integrate stress testing into a broader range of cardiovascular assessments and treatments.
   
• Thus, these factors are anticipated to contribute significantly to the market growth.

U.S. stress tests equipment market accounted for USD 825 million revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The region experiences a high prevalence of cardiovascular diseases, prompting an increased demand for diagnostic tools like stress tests.
   
• For instance, in 2021, according to the American Heart Association, 77.5 percent of men and 75.4 percent of women aged 60 to 79 have some form of cardiovascular disease.
   
• Further, as U.S. is a hub for medical technology innovation so there is a continuous advancement in stress test equipment technology, including improved ergometry features and integrated monitoring systems, that drives the market growth.
   

Stress Tests Equipment Market Share

The stress tests equipment industry is consolidated, with key players including GE Healthcare, Philips Healthcare (Koninklijke Philips N.V.), Siemens Healthineers, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in October 2023, Mediport and GE HealthCare inaugurate the One-Stop Clinic for Cardiology in Antwerp, Belgium. The center aims to offer a cardiology-based diagnosis pathway including several diagnosis tests like stress test, and other diagnosis test. This strategic merger enhances GE HealthCare's diagnostic capabilities, expanding its European market portfolio.
 

Stress Tests Equipment Market Companies

Some of the eminent market participants operating in the stress tests equipment industry include

• GE Healthcare
• Cardinal Health, Inc.
• Philips Healthcare (Koninklijke Philips N.V.)
• Siemens Healthineers (Siemens AG)
• Hill-Rom Holdings, Inc. (Baxter International Inc.)
• Schiller AG
• Nihon Kohden
• Spacelabs Healthcare (OSI Systems)
• Cosmed Medical
• Trismed Co. Ltd
• Cardiomed Europe P.C
   

Stress Tests Equipment Industry News

• In April 2022, GE Healthcare Korea and DeepCardio entered into a collaboration to co-develop AI-based ECG diagnosis technology and analysis programs. Utilizing GE Healthcare's 'MUSE' ECG data management system and DeepCardio's AI technology aimed to enhance cardiac assessment through integrated solutions. This collaboration provided a competitive edge for the company.
   
• In January 2022, Spacelabs Healthcare, a division of OSI Systems, Inc., unveiled the Cardiopulse Go and Cardiopulse Prime resting electrocardiograph (ECG) devices. These advanced products aimed to enhance workflow efficiency and bolstered the company's product portfolio, capturing market attention.
   

Stress test equipment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product Type

• Treadmill stress test systems
• Ergometry equipment
• Cardiopulmonary exercise testing (CPET) equipment
• Exercise ECG systems
• Echocardiogram
• Supplies & accessories

Market, By End-use

• Hospitals & clinics
• Diagnostic centers
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa